Countries North America
NG-350A combined with chemoradiotherapy demonstrated promising efficacy and a favorable safety profile Composite response rate of 50 percent observed ac...
April 21, 2026 | News
Orthogon Therapeutics announced the closing of an $11 million follow-on financing, bringing the total capital raised to $36 million. The financing will ena...
April 21, 2026 | News
First-in-human study of EPI-326 will evaluate the company’s lead tissue-selective EGFR degrader in patients with NSCLC and HNSCC with potential to ...
April 21, 2026 | News
SYNTHBODY™ introduces a new class of “smart drugs”: protein therapeutics with built-in, multi-layered logic gates that actively chang...
April 20, 2026 | News
St. Louis site strengthens integrated support for biopharma manufacturing Avantor, Inc, a leading global provider of mission-critical products and ser...
April 20, 2026 | News
New slurried chromatography resins eliminate resin hydration step to help accelerate downstream purification of oligonucleotides and peptides DuPont annou...
April 20, 2026 | News
First FDA-cleared rapid fentanyl test of its kind made in the United States designed to help emergency department and hospital teams ...
April 20, 2026 | News
A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible res...
April 17, 2026 | News
Protaryx Medical, an innovative medical device company developing disruptive access solutions for minimally invasive left-heart procedures, announced that ...
April 15, 2026 | News
VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, today announced MuteFree™ AAV, a high-stability AAV vector designed ...
April 15, 2026 | News
Thermo Fisher Scientific, the world leader in serving science, announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD) ...
April 14, 2026 | News
The multi-year collaboration aims to scale molecular data storage infrastructure and unlock breakthrough cost efficiencies by 2030. GenScript Biotech Corp...
April 14, 2026 | News
Advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery technologies Vivatides Therapeutics, a global biotechnology ...
April 13, 2026 | News
Bosaya™ and Aukelso™ (both denosumab-kyqq products) now available in the United States, following U.S. FDA approval in September 2025 with ...
April 10, 2026 | News
Most Read
Bio Jobs
News
Editor Picks